Bank of New York Mellon
GRTS

Bank of New York Mellon’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History

Bank of New York Mellon’s Portfolio GRTS Stock Details GRTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-316,861
Closed -$814K – 4298
2024
Q1 		$814K Sell
316,861
-9,663
-3% -$23.6K ﹤0.01% 3258
2023
Q4 		$666K Buy
326,524
+53,741
+20% +$98.1K ﹤0.01% 3398
2023
Q3 		$469K Sell
272,783
-17,153
-6% -$30.5K ﹤0.01% 3579
2023
Q2 		$565K Buy
289,936
+240,903
+491% +$564K ﹤0.01% 3521
2023
Q1 		$136K Hold
49,033
– – ﹤0.01% 4019
2022
Q4 		$169K Sell
49,033
-132
-0.3% -$377 ﹤0.01% 4018
2022
Q3 		$126K Sell
49,165
-2,020
-4% -$6.43K ﹤0.01% 4155
2022
Q2 		$124K Sell
51,185
-108,669
-68% -$285K ﹤0.01% 4186
2022
Q1 		$658K Buy
159,854
+2,506
+2% +$13.3K ﹤0.01% 3553
2021
Q4 		$2.02M Sell
157,348
-2,026
-1% -$22.4K ﹤0.01% 2991
2021
Q3 		$1.72M Buy
159,374
+26,262
+20% +$239K ﹤0.01% 3076
2021
Q2 		$1.22M Buy
133,112
+20,142
+18% +$186K ﹤0.01% 3292
2021
Q1 		$1.06M Buy
112,970
+24,322
+27% +$335K ﹤0.01% 3294
2020
Q4 		$349K Sell
88,648
-3,321
-4% -$10K ﹤0.01% 3767
2020
Q3 		$243K Buy
91,969
+72
+0.1% +$267 ﹤0.01% 3781
2020
Q2 		$611K Buy
91,897
+9,815
+12% +$66.1K ﹤0.01% 3375
2020
Q1 		$478K Buy
82,082
+180
+0.2% +$1.51K ﹤0.01% 3393
2019
Q4 		$735K Buy
81,902
+3,111
+4% +$25.9K ﹤0.01% 3384
2019
Q3 		$680K Sell
78,791
-1,071
-1% -$10.8K ﹤0.01% 3381
2019
Q2 		$890K Buy
79,862
+57,924
+264% +$662K ﹤0.01% 3297
2019
Q1 		$292K Buy
+21,938
New +$293K ﹤0.01% 3749

Other funds holding GRTS

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Bank of New York Mellon's GRTS Position: Q2 2024 in Review

Bank of New York Mellon sold out of Gritstone bio, Inc. Common Stock (GRTS) in Q2 2024, closing a stake of 316,861 shares — an estimated $814K sold.

Bank of New York Mellon first reported a position in GRTS in Q1 2019 and held it in 21 quarters. The position peaked at $2.02M in Q4 2021. 79 funds tracked by Wall St. Rank hold GRTS as of Q2 2024.

  • Bank of New York Mellon reported no remaining Gritstone bio, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Bank of New York Mellon sold 316,861 Gritstone bio, Inc. Common Stock shares in Q2 2024, an estimated $814K.
  • Bank of New York Mellon first reported a position in Gritstone bio, Inc. Common Stock in Q1 2019 and held it in 21 quarters.
  • Bank of New York Mellon's Gritstone bio, Inc. Common Stock position peaked at $2.02M in Q4 2021.
  • 79 funds tracked by Wall St. Rank held Gritstone bio, Inc. Common Stock as of Q2 2024.

Based on Bank of New York Mellon's 13F filing for Q2 2024, filed 25 Jul 2024.